Related Experiment Video
Updated: Aug 18, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Adrenoleukodystrophy carrier state presenting as a chronic nonprogressive spinal cord disorder
Abstract:
Females who are heterozygous for adrenoleukodystrophy (ALD) can be identified biochemically. Since most carriers for this disease are asymptomatic, their diagnosis usually occurs only after neurologically abnormal male relatives have been investigated. We describe a woman with a chronic nonprogressive spinal cord syndrome secondary to the ALD heterozygote state. The neurologic condition in this patient suggests that the diagnosis of ALD should be considered in women with evidence of white matter disease.
Related Concept Videos
Parkinson's Disease: Overview
Multiple Sclerosis l: Introduction
Alzheimer Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology

